Bone Biologics Corp (NASDAQ: BBLG)
$1.2700
+0.0200 ( +1.60% ) 0.0K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.2700
Previous close
$1.2500
Volume
0.0K
Market cap
$3.08M
Day range
$1.2500 - $1.2500
52 week range
$0.8000 - $10.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 19 | Nov 20, 2023 |
def | Proxies and info statements | 3 | Nov 20, 2023 |
10-k/a | Quarterly Reports | 16 | Nov 20, 2023 |
10-q | Quarterly Reports | 55 | Nov 14, 2023 |
pre | Proxies and info statements | 3 | Nov 09, 2023 |